Comparative Study Between Aripiprazole and Clozapine in the Treatment of Schizophrenia
Mao Wei-lan
Abstract
Mao Wei-lan
Abstract
Objective:To study the clinical efficacy and side effect of aripiprazole in the treatment of first-episode schizophrinia.Method: Forty-six schizophrenic patients were randomly divided into aripiprazole group and clozapine group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and side effects respectively.Result:There were no significant difference in the total caraive effects between two groups(P0.05).Aripiorazole had less side effects than clozapine did.Conclusion:Aripiprazole is a safe and effective antipcychotic drug.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the clinical efficacy and side effect of aripiprazole in the treatment of first-episode schizophrinia.Method: Forty-six schizophrenic patients were randomly divided into aripiprazole group and clozapine group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and side effects respectively.Result:There were no significant difference in the total caraive effects between two groups(P0.05).Aripiorazole had less side effects than clozapine did.Conclusion:Aripiprazole is a safe and effective antipcychotic drug.
Key concepts: Aripiprazole, Medicine, Clozapine, Schizophrenia (object-oriented programming), Side effect (computer science), Clinical efficacy, Drug, Psychiatry